MUSK and myasthenia gravis: Additionally, RTX is often used off-label in many immune-mediated conditions (Stubgen, 2008), including MG (Tandan et al., 2017; Vesperinas-Castro and Cortés-Vicente, 2023), particularly in cases associated with MuSK antibodies (Vakrakou et al., 2023).